정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
2200 | Recruiting | Anosmia and / or Ageusia and Early Corticosteroid Use | Anosmia | Drug: Early-Dexamethasone Drug: Late dexamethazone |
Phase 4 | ClinAmygate | OTHER | 300 | All | 18 Years | Asalam, Maadi, Cairo, Egypt |
2199 | Withdrawn | Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) | Olfactory Disorder | Other: Olfactory retraining Drug: corticosteroid nasal irrigation Other: smell household Items Other: Nasal Irrigation |
Phase 4 | Lawson Health Research Institute | OTHER | 0 | All | 18 Years | St. Joseph's Health Care, London, Ontario, Canada |
2198 | Recruiting | Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients | Covid19 | Biological: Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) | Phase 3 | Dow University of Health Sciences, Higher Education Commission (Pakistan) | OTHER | 310 | All | 18 Years | Dow University of Health Sciences, Karachi, Sindh, Pakistan |
2197 | Recruiting | Anti COVID-19 Convalescent Plasma Therapy | COVID 19 | Biological: anti-SARS-CoV-2 convalescent plasma | Early Phase 1 | Orthosera Kft., Semmelweis University, University of Pecs, Hungarian National Blood Service, Human Bioplazma Kft - Kedrion | OTHER | 20 | All | 18 Years | Semmelweis University's Department of Pulmonology, Budapest, Hungary |
2196 | Completed | Anti-Androgen Treatment for COVID-19 | SARS (Severe Acute Respiratory Syndrome) | Drug: Proxalutamide Other: Standard of Care |
Not Applicable | Applied Biology, Inc. | INDUSTRY | 268 | Male | 18 Years | Corpometria Institute, Brasilia, Brazil |
2195 | Recruiting | Antibody Response to COVID-19 Vaccines in Liver Disease Patients | Chronic Liver Disease | Biological: BNT162b2 Biological: CoronaVac Biological: AZD1222 |
Phase 4 | Humanity & Health Medical Group Limited | OTHER | 900 | All | 18 Years | Humanity & Health Medical Group Limited, Hong Kong, Hong Kong |
2194 | Completed | ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) | Coronavirus Infections | Biological: COVID-19 convalescent plasma | Phase 2 | William Beaumont Hospitals | OTHER | 71 | All | 18 Years | William Beaumont Hospital, Royal Oak, Michigan, United States |